High yields of monomeric recombinant β‐interferon from macroporous microcarrier cultures under hypothermic conditions

Macroporous microcarriers such as Cytopore entrap mammalian cells in a mesh network allowing growth to high cell concentrations in a protected environment within a stirred culture. Chinese hamster ovary (CHO) cells producing recombinant human β‐interferon (IFN‐β) and grown in Cytopore microcarriers showed a 2.6‐ to 2.8‐fold increase in the volumetric product titer compared with cells grown in an equivalent suspension culture. In an attempt to maximize production of IFN‐β, microcarrier cultures were subjected to a low temperature regime. Low temperature culture conditions (32°C) have been shown previously to enhance cell specific productivity in suspension cultures although at reduced cell growth rates. These conditions can be optimized by a timely shift from physiological to hypothermic conditions during the culture run to maximize volumetric protein production. In the case of IFN‐β production the lower temperature has the added advantage of stabilizing the product and reducing intramolecular aggregation. Using a biphasic temperature‐shift regime from 37 to 32°C the volumetric production of IFN‐β was enhanced to 4.2‐fold compared with a single temperature suspension culture in a controlled bench‐top bioreactor. Furthermore, the degree of intramolecular aggregation of IFN‐β was reduced significantly (59%) compared with control cultures, largely due to the lower temperature but also partially due to the presence of microcarriers. These results indicate that the hypothermic conditions in a Cytopore culture had a combined and possibly synergistic effect of increasing volumetric production of the recombinant protein.

[1]  Xian-wen Hu,et al.  Pilot production of u-PA with porous microcarrier cell culture , 2000, Cytotechnology.

[2]  G. Lee,et al.  Adaptation of Chinese hamster ovary cells to low culture temperature: cell growth and recombinant protein production. , 2006, Journal of biotechnology.

[3]  K. Furukawa,et al.  Effect of culture temperature on a recombinant CHO cell line producing a C-terminal α-amidating enzyme , 1998, Cytotechnology.

[4]  D. Kong,et al.  High cell density and productivity culture of Chinese hamster ovary cells in a fluidized bed bioreactor , 2004, Cytotechnology.

[5]  J. Nam,et al.  Cell Attachment to Microcarriers Affects Growth, Metabolic Activity, and Culture Productivity in Bioreactor Culture , 2008, Biotechnology progress.

[6]  M. Butler,et al.  Optimization of physical parameters for cell attachment and growth on macroporous microcarriers , 1996, Biotechnology and bioengineering.

[7]  H. Zhou,et al.  Role of proline, glycerol, and heparin as protein folding aids during refolding of rabbit muscle creatine kinase. , 2001, The international journal of biochemistry & cell biology.

[8]  M. M. Antoniazzi,et al.  Rabies virus production in high vero cell density cultures on macroporous microcarriers , 2004, Biotechnology and bioengineering.

[9]  M. Butler,et al.  Production of reovirus type-1 and type-3 from Vero cells grown on solid and macroporous microcarriers. , 1999, Biotechnology and bioengineering.

[10]  C. Pereira,et al.  Higher production of rabies virus in serum-free medium cell cultures on microcarriers. , 2001, Journal of biotechnology.

[11]  M. Butler,et al.  Application of a serum-free medium for the growth of Vero cells and the production of reovirus. , 2000, Biotechnology progress.

[12]  M. Butler,et al.  Production and Glycosylation of Recombinant β‐Interferon in Suspension and Cytopore Microcarrier Cultures of CHO Cells , 2008, Biotechnology progress (Print).

[13]  G. Liao,et al.  A novel process for production of hepatitis A virus in Vero cells grown on microcarriers in bioreactor. , 2004, World journal of gastroenterology.

[14]  Xingmao Liu,et al.  Temperature shift as a process optimization step for the production of pro-urokinase by a recombinant Chinese hamster ovary cell line in high-density perfusion culture. , 2004, Journal of bioscience and bioengineering.

[15]  Gyun Min Lee,et al.  Enhancing Effect of Low Culture Temperature on Specific Antibody Productivity of Recombinant Chinese Hamster Ovary Cells: Clonal Variation , 2004, Biotechnology progress.

[16]  S. R. Fox,et al.  Maximizing interferon‐γ production by chinese hamster ovary cells through temperature shift optimization: Experimental and modeling , 2004, Biotechnology and Bioengineering.

[17]  M. Butler,et al.  Enhanced Production of Monomeric Interferon‐β by CHO Cells through the Control of Culture Conditions , 2008, Biotechnology progress.

[18]  D. Lütkemeyer,et al.  High-density culture of recombinant Chinese hamster ovary cells producing prothrombin in protein-free medium , 2001, Biotechnology Letters.

[19]  T. Faure,et al.  Production of recombinant Von Willebrand factor by CHO cells cultured in macroporous microcarriers , 1990, Cytotechnology.

[20]  A. Whitty,et al.  The structure of human interferon-β: implications for activity , 1998, Cellular and Molecular Life Sciences CMLS.

[21]  Dooha Kim,et al.  Effect of glycerol on protein aggregation: Quantitation of thermal aggregation of proteins from CHO cells and analysis of aggregated proteins , 1993 .

[22]  Y. Shirai,et al.  Changes in monoclonal antibody productivity of recombinant BHK cells immobilized in collagen gel particles , 2004, Cytotechnology.

[23]  S. Harcum,et al.  Temperature Effects on Product‐Quality‐Related Enzymes in Batch CHO Cell Cultures Producing Recombinant tPA , 2004, Biotechnology progress.

[24]  Marina Etcheverrigaray,et al.  Impact of temperature reduction and expression of yeast pyruvate carboxylase on hGM-CSF-producing CHO cells. , 2004, Journal of biotechnology.

[25]  B. Domon,et al.  Expression, purification, and characterization of rat interferon-beta, and preparation of an N-terminally PEGylated form with improved pharmacokinetic parameters. , 2004, Protein expression and purification.

[26]  K Konstantinov,et al.  Fermentor temperature as a tool for control of high-density perfusion cultures of mammalian cells. , 1997, Biotechnology and bioengineering.

[27]  G. Blüml,et al.  Scalable inoculation strategies for microcarrier‐based animal cell bioprocesses , 2003, Biotechnology and bioengineering.

[28]  Nigel Jenkins,et al.  Getting the glycosylation right: Implications for the biotechnology industry , 1996, Nature Biotechnology.

[29]  L. Munari,et al.  Interferons in relapsing remitting multiple sclerosis : a systematic review , 2022 .

[30]  Terrance A Stadheim,et al.  Challenges in therapeutic glycoprotein production. , 2006, Current opinion in biotechnology.

[31]  I. Kanazawa,et al.  Chemical Chaperones Reduce Aggregate Formation and Cell Death Caused by the Truncated Machado–Joseph Disease Gene Product with an Expanded Polyglutamine Stretch , 2002, Neurobiology of Disease.

[32]  D. Andersen,et al.  Recombinant protein expression for therapeutic applications. , 2002, Current opinion in biotechnology.

[33]  M. Butler,et al.  Erythropoietin production from CHO cells grown by continuous culture in a fluidized-bed bioreactor. , 2002, Biotechnology and bioengineering.

[34]  Sung Hyun Kim,et al.  Effect of Low Culture Temperature on Specific Productivity and Transcription Level of Anti‐4–1BB Antibody in Recombinant Chinese Hamster Ovary Cells , 2008, Biotechnology progress.

[35]  A. Mccarthy Development , 1996, Current Opinion in Neurobiology.

[36]  D K Robinson,et al.  Industrial choices for protein production by large-scale cell culture. , 2001, Current opinion in biotechnology.

[37]  Adrian Whitty,et al.  Structural and Functional Differences Between Glycosylated and Non-glycosylated Forms of Human Interferon-β (IFN-β) , 1998, Pharmaceutical Research.

[38]  B. Shen,et al.  Controlled Growth of Chinese Hamster Ovary Cells and High Expression of Antibody-IL-2 Fusion Proteins by Temperature Manipulation , 2005, Biotechnology Letters.

[39]  Suh-Chin Wu,et al.  Optimization of microcarrier cell culture process for the inactivated enterovirus type 71 vaccine development. , 2004, Vaccine.

[40]  N. Kochibe,et al.  Comparative study of the asparagine-linked sugar chains of natural human interferon-beta 1 and recombinant human interferon-beta 1 produced by three different mammalian cells. , 1988, The Journal of biological chemistry.

[41]  Xian-wen Hu,et al.  High density and scale-up cultivation of recombinant CHO cell line and hybridomas with porous microcarrier Cytopore , 1999, Cytotechnology.

[42]  B. Arnason,et al.  Immunologic therapy of multiple sclerosis. , 1999, Annual review of medicine.